Literature DB >> 31391150

Cause or cure? Review of dupilumab and alopecia areata.

Dustin H Marks1, Natasha Mesinkovska2, Maryanne M Senna3.   

Abstract

Entities:  

Year:  2019        PMID： 31391150     DOI： 10.1016/j.jaad.2019.06.010

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Hair Growth in a Patient with Alopecia Areata on Tocilizumab.

Authors:  Chloe J Walker; Kelly E Flanagan; James T Pathoulas; Isabel Pupo Wiss; Maryanne M Senna
Journal:  Skin Appendage Disord       Date:  2021-06-09

2.  Dupilumab, incontinentia pigmenti, and alopecia: A serendipitous observation.

Authors:  Ashley Torkan Zilberstein; Erica L Teng; Anthony J Mancini
Journal:  JAAD Case Rep       Date:  2022-09-21

3.  Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.

Authors:  Maurizio Romagnuolo; Mauro Barbareschi; Simona Tavecchio; Luisa Angileri; Silvia Mariel Ferrucci
Journal:  Skin Appendage Disord       Date:  2021-07-27

4.  Dupilumab for the treatment of alopecia areata in children with atopic dermatitis.

Authors:  Sung Kyung Cho; Brittany G Craiglow
Journal:  JAAD Case Rep       Date:  2021-07-27

Review 5.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

6.  Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.

Authors:  Sunny Park; So Hyang Park; Young Joo Byun; Soo An Choi
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.